{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:20:45Z","timestamp":1790115645440,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009576","name":"Nantong City Health Commission","doi-asserted-by":"publisher","award":["MSZ2023061"],"award-info":[{"award-number":["MSZ2023061"]}],"id":[{"id":"10.13039\/501100009576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Health Commission","doi-asserted-by":"publisher","award":["LKM2022062"],"award-info":[{"award-number":["LKM2022062"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research: Cognition"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.scog.2025.100396","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:28:47Z","timestamp":1760549327000},"page":"100396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A clinical control study of modified electroconvulsive therapy and sodium valproate as enhancement strategies for ultra-treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"43","author":[{"given":"Peijuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scog.2025.100396_bb0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5498\/wjp.v11.i8.429","article-title":"Clozapine resistant schizophrenia: newer avenues of management","volume":"11","author":"Chakrabarti","year":"2021","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1381612826666200110102254","article-title":"Augmentation strategies for clozapine-resistant patients with schizophrenia","volume":"26","author":"Chiu","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.scog.2025.100396_bb0015","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1080\/14656566.2022.2145884","article-title":"Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia","volume":"23","author":"de Bartolomeis","year":"2022","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.scog.2025.100396_bb0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMra2034954","article-title":"Electroconvulsive therapy","volume":"386","author":"Espinoza","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.scog.2025.100396_bb0025","article-title":"Clozapine versus typical neuroleptic medication for schizophrenia","volume":"2009","author":"Essali","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.scog.2025.100396_bb0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.psychres.2017.01.042","article-title":"Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: a retrospective study","volume":"249","author":"Grover","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.scog.2025.100396_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpsychires.2019.08.011","article-title":"Randomized controlled trial of adjunctive valproate for cognitive remediation in early course schizophrenia","volume":"118","author":"Ibrahim","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.scog.2025.100396_bb0050","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00517-8","article-title":"Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation","volume":"380","author":"Ichikawa","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.scog.2025.100396_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2005.05.005","article-title":"Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism","volume":"1049","author":"Ichikawa","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.scog.2025.100396_bb0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.2758","article-title":"Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond","volume":"36","author":"Koola","year":"2021","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.scog.2025.100396_bb0070","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method: table 1","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.scog.2025.100396_bb0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S2215-0366(23)00109-8","article-title":"An international research agenda for clozapine-resistant schizophrenia","volume":"10","author":"Luykx","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/FTD.0000000000000513","article-title":"Effect of valproate and antidepressant drugs on clozapine metabolism in patients with psychotic mood disorders","volume":"40","author":"Marazziti","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.scog.2025.100396_bb0085","first-page":"139","article-title":"Cognitive deficit in schizophrenia: an overview","volume":"31","author":"Mihaljevi\u0107-Pele\u0161","year":"2019","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.scog.2025.100396_bb0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamapsychiatry.2021.3799","article-title":"Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia","volume":"79","author":"Pardi\u00f1as","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-1781(94)90093-0","article-title":"Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia","volume":"53","author":"Peralta","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.scog.2025.100396_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","article-title":"Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study","volume":"172","author":"Petrides","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.scog.2025.100396_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110042","article-title":"Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: does UGT polymorphism affect these drug interactions?","volume":"364","author":"Sang\u00fcesa","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.scog.2025.100396_bb0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1126\/science.1070532","article-title":"Schizophrenia: diverse approaches to a complex disease","volume":"296","author":"Sawa","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.scog.2025.100396_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpsychires.2019.05.008","article-title":"Meta-analysis of the positive and negative syndrome scale (PANSS) factor structure","volume":"115","author":"Shafer","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.scog.2025.100396_bb0130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41582-020-0364-0","article-title":"The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology","volume":"16","author":"Smeland","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.scog.2025.100396_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/JCP.0000000000001126","article-title":"The effect of valproic acid on olanzapine serum concentration: a study including 2791 patients treated with olanzapine tablets or long-acting injections","volume":"39","author":"Tveito","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.scog.2025.100396_bb0140","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.23r15045","article-title":"Cognitive effects of electroconvulsive therapy in schizophrenia: a systematic review","volume":"85","author":"Vaccarino","year":"2024","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41398-019-0530-6","article-title":"Hippocampal volume change following ECT is mediated by rs699947 in the promotor region of VEGF","volume":"9","author":"Van Den Bossche","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0150","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/s41380-022-01572-0","article-title":"Dopaminergic dysfunction and excitatory\/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment","volume":"27","author":"Wada","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0155","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/schbul\/sbaa060","article-title":"Clozapine combination and augmentation strategies in patients with schizophrenia -recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group","volume":"46","author":"Wagner","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.scog.2025.100396_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01613-2","article-title":"Efficacy and safety of clozapine in psychotic disorders\u2014a systematic quantitative meta-review","volume":"11","author":"Wagner","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2018.08.002","article-title":"ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials","volume":"105","author":"Wang","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.scog.2025.100396_bb0170","article-title":"A systematic review of methods and study quality of economic evaluations for the treatment of schizophrenia","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.scog.2025.100396_bb0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1192\/bjp.181.3.184","article-title":"Clozapine-resistant schizophrenia: a positive approach","volume":"181","author":"Williams","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.scog.2025.100396_bb0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bdi.13317","article-title":"Serum angioneurin levels following electroconvulsive therapy for mood disorders","volume":"25","author":"Zhang","year":"2023","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.scog.2025.100396_bb0185","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.4088\/JCP.16r10782","article-title":"Clozapine augmentation with antiepileptic drugs for treatment-resistant schizophrenia: a meta-analysis of randomized controlled trials","volume":"78","author":"Zheng","year":"2017","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research: Cognition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221500132500054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221500132500054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:51:44Z","timestamp":1765558304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221500132500054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S221500132500054X"],"URL":"https:\/\/doi.org\/10.1016\/j.scog.2025.100396","relation":{},"ISSN":["2215-0013"],"issn-type":[{"value":"2215-0013","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical control study of modified electroconvulsive therapy and sodium valproate as enhancement strategies for ultra-treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research: Cognition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scog.2025.100396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100396"}}